Company Amalex Clinical Research Srl with Fiscal Code 33462952
recorded a turnover of 2024 of
- ,
with a net profit of
-5.563
and having an average number of employees of
- .
The company operates in the field of Cercetare-dezvoltare in biotehnologie having the NACE code 7211.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Amalex Clinical Research Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
117.029
128.527
129.777
110.228
187.591
190.688
134.007
153.372
161.918
0
Total Income - EUR
117.771
130.416
132.298
111.444
190.156
195.275
137.759
160.190
168.960
921
Total Expenses - EUR
66.020
71.259
59.850
67.884
92.898
86.619
60.060
94.212
77.170
6.484
Gross Profit/Loss - EUR
51.751
59.156
72.448
43.559
97.259
108.655
77.699
65.978
91.790
-5.563
Net Profit/Loss - EUR
41.421
48.700
70.609
42.457
95.376
105.054
76.359
64.545
90.203
-5.563
Employees
2
3
3
2
2
1
2
2
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Check the financial reports for the company - Amalex Clinical Research Srl
Financial Rating - AMALEX CLINICAL RESEARCH SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Amalex Clinical Research Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Amalex Clinical Research Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Amalex Clinical Research Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Amalex Clinical Research Srl - CUI 33462952
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
32.378
25.294
18.421
10.836
3.779
0
812
1.516
490
0
Current Assets
33.703
58.882
75.598
97.760
137.125
216.046
266.296
290.039
353.714
345.511
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
13.634
16.172
36.710
35.920
53.173
64.757
58.008
42.473
58.859
56.637
Cash
12.111
42.711
38.887
61.839
83.952
151.288
208.287
247.565
294.855
288.874
Shareholders Funds
41.475
48.754
70.661
42.509
95.426
105.104
179.132
64.594
90.252
84.184
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
27.600
37.958
24.757
66.757
46.607
111.177
89.565
227.006
264.038
261.327
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7211 - 7211"
CAEN Financial Year
7211
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
345.511 euro in 2024 which includes Inventories of
0 euro, Receivables of
56.637 euro and cash availability of
288.874 euro.
The company's Equity was valued at
84.184 euro, while total Liabilities amounted to
261.327 euro.
Equity decreased by -5.563 euro, from 90.252 euro in 2023, to 84.184 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Amalex Clinical Research Srl